English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Daniel Jamieson is the CEO and Founder of Biorelate, a biomedical curation company that aims to accelerate insights and innovation in future drug discovery. Daniel started Biorelate in the midst of a computational biology PhD at the University of Manchester after the successful identification of drug repurposing opportunities with Pfizer. He is now coming up to 7 years into that journey, and his focus remains on turning Biorelate into a world-leading enterprise, helping pioneering companies and researchers in their mission to develop life-saving innovations. The Biochemist spoke to Daniel about the journey so far.

Accelerating research intelligence with AI: an interview with Daniel Jamieson, CEO and Founder of Biorelate